Skip to main content
. 2022 May 2;12:856345. doi: 10.3389/fonc.2022.856345

Table 2.

Clinical Characteristics of Participants with Crohn’s disease or Ulcerative Primary Intestinal Lymphoma.

Characteristics UPIL (n = 50) CD (n = 91) Regression coefficient OR (95% CI) P*
Clinical Manifestations, n (%)
Fever 28 (56.0%) 39 (42.86%) −0.52 0.59 (0.29–1.18) 0.14
Nausea 5 (10.0%) 20 (21.98%) 0.93 2.54 (0.95–8.05) 0.08
Abdominal Pain 41 (82.0%) 80 (87.91%) 0.47 1.60 (0.60–4.17) 0.34
Diarrhea 28 (56.0%) 62 (68.13%) 0.52 1.68 (0.82–3.43) 0.15
Hematochezia 21 (42.0%) 28 (30.77%) −0.49 0.61 (0.30–1.26) 0.18
Perianal lesions 0 42 (46.15%) 18.59 0.99
Anorexia 22 (44.0%) 27 (29.67%) −0.62 0.54 (0.26–1.10) 0.09
Weight loss 36 (72.0%) 62 (68.13%) −0.18 0.83 (0.38–1.76) 0.63
Abdominal mass 8 (16.0%) 9 (9.89%) −0.55 0.58 (0.21–1.64) 0.29
Onset Symptoms, n (%)
Abdominal pain 32 (64.0%) 53 (58.24%) −0.24 0.78 (0.38–1.59) 0.50
Diarrhea 26 (52.0%) 46 (50.55%) −0.06 0.94 (0.47–1.88) 0.87
Perianal lesions 1 (2.0%) 18 (19.78%) 2.49 12.08 (2.37–220.89) 0.02
Complications, n (%)
Abdominal abscess 2 (4.00%) 5 (5.49%) 0.33 1.40 (0.29–10.00) 0.70
Intestinal fistulas 5 (10.00%) 15 (16.48%) 0.57 1.78 (0.64–5.76) 0.30
Intestinal stenosis 9 (18.00%) 41 (45.05%) 1.32 3.74 (1.68–9.01) 0.002
Intestinal obstruction 9 (18.00%) 18 (19.78%) 0.12 1.12 (0.47–2.83) 0.80
Intestinal perforation 14 (28.00%) 1 (1.10%) −3.56 0.03 (0.002–0.15) <0.001
Intestinal bleeding 15 (30.00%) 7 (7.69%) −1.64 0.19 (0.07–0.50) 0.001
EIMs 7 (14.00%) 35 (38.46%) 1.35 3.84 (1.63–10.18) 0.004
History of appendectomy 5 (10.00%) 12 (13.19%) 0.31 1.37 (0.47–4.52) 0.58
Smoking, n (%) 19 (38.00%) 23 (25.27%) −0.59 0.55 (0.26–1.16) 0.12
Drinking, n (%) 16 (32.00%) 13 (14.29%) −1.04 0.35 (0.15–0.81) 0.01

CD, Crohn’s disease; UPIL, Ulcerative Primary intestinal lymphoma; EIMs, extraintestinal manifestations.

*Univariate logistic regression is used.